ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.5884
-0.0186 (-3.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed

ProMIS Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
2.78-13.21-18.06-9.79-4.44
Upgrade
Depreciation & Amortization
-0.020.010.050.01
Upgrade
Other Amortization
--0.240.37-
Upgrade
Loss (Gain) From Sale of Assets
----0.06-
Upgrade
Stock-Based Compensation
0.830.270.490.520.21
Upgrade
Other Operating Activities
-19.06-0.87-5.111.180.12
Upgrade
Change in Accounts Receivable
----0.03
Upgrade
Change in Accounts Payable
-6.114.962.68-0.030.07
Upgrade
Change in Other Net Operating Assets
-5.62-2.022.73-1.530.59
Upgrade
Operating Cash Flow
-27.18-10.84-17.03-9.31-3.42
Upgrade
Capital Expenditures
---0-0.01-0.09
Upgrade
Sale of Property, Plant & Equipment
---0.1-
Upgrade
Investment in Securities
-0-0-0-0
Upgrade
Investing Cash Flow
-0-0-00.09-0.09
Upgrade
Long-Term Debt Issued
---6.92-
Upgrade
Total Debt Issued
---6.92-
Upgrade
Net Debt Issued (Repaid)
---6.92-
Upgrade
Issuance of Common Stock
27.8817.754.9715.873.01
Upgrade
Other Financing Activities
--1.522.74-
Upgrade
Financing Cash Flow
27.8817.756.4925.523.01
Upgrade
Foreign Exchange Rate Adjustments
--0.18-0.53-0.18-
Upgrade
Net Cash Flow
0.696.72-11.0716.14-0.5
Upgrade
Free Cash Flow
-27.18-10.84-17.04-9.31-3.5
Upgrade
Free Cash Flow Margin
-----285250.81%
Upgrade
Free Cash Flow Per Share
-1.03-0.88-2.27-1.61-0.74
Upgrade
Levered Free Cash Flow
-19.28-5.32-8.01-6.11-1.81
Upgrade
Unlevered Free Cash Flow
-19.23-5.19-8.07-6.22-1.81
Upgrade
Change in Net Working Capital
11.73-2.93-5.231.59-0.72
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q